Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery dise...
Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial
About this item
Full title
Author / Creator
Ge Jun-Bo , Fan Wei-Hu , Zhou Jing-Min , Shi Hai-Ming , Ji Fu-Sui , Wu Yang , Zhao Yu-Lan , Qian Jun , Jin Yuan-Zhe , Liu Ying-Wu , Wang Sheng-Huang , He Sheng-Hu , Yang Ping , Wu Jie , Lu Feng and Hou Zi-Shan
Publisher
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China%Department of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, China%Department of Cardiology, Beijing Hospital of the Ministry of Health, Beijing 100730, China%Department of Cardiology, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China%Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China%Department of Cardiology, The Center Hospital of Ma'anshan, Ma'anshan, Anhui 243000, China%Department of Cardiology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning 110032, China%Department of Cardiology, Tianjin Third Central Hospital, Tianjin 300170, China%Department of Cardiology, Ningbo First Hospital, Ningbo, Zhejiang 315010, China%Department of Cardiology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu 210036, China%Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130031, China%Department of Cardiology, The First Affiliated Hospital of University of South China, Hengyang, Hunan 421000, China%Department of Cardiology, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China
Journal title
Language
Chinese
Formats
Publication information
Publisher
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China%Department of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, China%Department of Cardiology, Beijing Hospital of the Ministry of Health, Beijing 100730, China%Department of Cardiology, Dongfang Hospital Affiliated to Beijing University of Chines...
More information
Scope and Contents
Contents
Background::The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The aim of the study is to determine the effects of MUSKARDIA as an add-on to optimal medical therapy (O...
Alternative Titles
Full title
Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_wanfang_journals_zhcmj202102013
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_wanfang_journals_zhcmj202102013
Other Identifiers
ISSN
0366-6999
DOI
10.1097/CM9.0000000000001257
